Drug Industry


Drug Company Funding Disclosures

    Eli Lilly: payments to individuals

      grants to organizations


    GlaxoSmithKline: payments to individuals

      grants to organizations


    Merck: payments to individuals

      grants to organizations


    Pfizer: payments to individuals

      grants to organizations


    Cephalon: payments to individuals

    Minnesota Board of Pharmacy Payments to Practitioners Documents

    Pharmaceutical Marketing Disclosures: Report of Vermont Attorney General William H. Sorrell on Payments to Physicians (read more)



Blogs (link to list)



Cafepharma: Drug Rep Message Board



Pharmaceutical Research and Manufacturers of America (PhRMA): Trade Group

Major Global Companies

    Abbott Labs

    Akzo Nobel

    Alcon Labs

    Allergan

    Altana

    Amgen

    AstraZeneca

    Astrella Pharma US

    Bayer

    Bayer Schering Pharma AG

    Baxter International

    Biogen Idec

    Boehringer-Ingelheim

    Bristol-Myers Squibb

    Chugai

    Eisai

    Eil Lilly

    Forest Labs

    Genentech

    Genzyme

    GlaxoSmithKline

    Ivax Corporation

    Johnson and Johnson

    King Pharmaceuticals

    Lundbeck

    Merck

    Merck KGaA

    Mitsubishi Pharmaceuticals

    Mylan Labs

    Novartis

    Novo Nordisk

    Ono Pharmaceuticals

    Otsuka

    Pfizer

    Purdue

    Roche

    Sankyo

    Sanofi-Aventis

    Schering Plough

    Serono

    Shionogi Seiyaku

    Shire

    Solvay

    Takeda

    Teva

    UCB

    Watson

    Wyeth


Blogs (return to section menu)

Ratings of industry bias are from a survey by John Mack in Pharma Marketing News in March 2007.

Red = "Critical" of industry
Green = "Supportive" of industry
Blue = Balanced (from "Critical but Helpful" to "Supportive and helpful")

    BrandweekNRX

    Clincial Psych Blog

    Dr. Peter Rost

    Drug Injury Watch

    Drug Wonks

    eDrugSearch Blog

    EyeOnFDA

    HealthcareVOX

    Impactiviti

    In the Pipeline

    On Pharma

    OnThePharm

    Pharma Giles

    Pharma Gazette

    Pharma Marketing Blog

    Pharma Rag

    Pharma Watch

    PharmaEdge

    PharmaGossip

    Pharmalot

    World of DTC Marketing

    More Blogs
(back to Resources by Topic or Resources by Type)

Our Videos



Pharma Insider II
Opposition research
(read transcript)


Pharma Insider I
Off-label promotion under the radar
(read transcript)

The Art of Medical Writing
Pharma's anonymous writers

Drug Reps Talk Shop II
Drug reps continue their chat

Drug Reps Talk Shop I Selling drugs to docs

Director of PharmedOut Explains the Project

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug
News

Drug Firms Turn to Private Docs to Promote Products
University ethics policies tightened Milwaukee Journal Sentinel
J&J Pushed Risperdal After Warning, Files Show
FDA ignored; CME supported off-label uses Bloomberg
NIH Should Disclose Financial Conflicts
Public database requested Pharmalot
Diabetes Heart Treatments May Cause Harm
Normalizing BP and postprandial hyperglycemia don't help NYT
Grassley Tells PBMs To Disclose Ties To Pharma
Drugmakers may provide financial benefits Pharmalot
Analysis Finds Vioxx's Heart Attack Risk in 2001
35% increase in CV events WSJ
States, Consumer Advocates Challenge Rx Data Mining
FDA has been silent Chicago Tribune
Researcher Seeks New Treatments in Old Drugs
Bioinformatics promising Houston Chronicle
Some Doctors Say No More Free Lunches
“Goodies” are a conflict of interest Rapid City Journal
Study Raises Questions About Cholesterol Drug’s Benefit
Niacin bests Zetia NYT
Drug Makers Raise Prices in Face of Health Care Reform
Wholesale prices up 9% NYT
Commentary

Mammography and the Corporate Breast
Conflicts of USPSTF critics not mentioned Bioethics Forum
Click HERE to read the entire news archives
All content on this site is © 2006 by PharmedOut * (p) 202-687-1191 * (f) 202-687-7407 * Georgetown University
Department of Physiology and Biophysics * Box 571460 * Washington, DC 20057-1460